scPharmaceuticals (SCPH) Schedule 13G: 4.0% Stake Reported

scPharmaceuticals Inc. had a Schedule 13G filing showing that Luther King Capital Management Corporation and J. Luther King, Jr. each report beneficial ownership of 2,128,391 shares, representing 4.0% of the outstanding common stock.

Rhea-AI Filing Summary

scPharmaceuticals Inc. had a Schedule 13G filing showing that Luther King Capital Management Corporation and J. Luther King, Jr. each report beneficial ownership of 2,128,391 shares, representing 4.0% of the outstanding common stock. The filing reports that the reporting persons have sole voting and sole dispositive power over these shares and that the holdings were acquired and are held in the ordinary course of business, not to influence control of the issuer. The filing classifies the institutional filer as an investment adviser/controller and confirms no shared voting or dispositive power and no group or 5%+ ownership status.

Positive

• Institutional position of 2,128,391 shares equals 4.0% ownership
• Sole voting and dispositive power reported for the full share amount

Negative

• Stake remains under 5% (4.0%), limiting formal influence on corporate control
• No shared voting power suggests concentration of authority but also no coalition disclosed

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake did Luther King Capital Management report in scPharmaceuticals (SCPH)?

They reported beneficial ownership of 2,128,391 shares, representing 4.0% of common stock.

Does Luther King Capital Management have voting control over its SCPH shares?

Yes. The filing shows sole voting power and sole dispositive power over all 2,128,391 shares reported.

Is the reported SCPH position intended to change control of the company?

No. The filing certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Do the reporting persons form a group or hold more than 5% of SCPH?

No. The filing indicates no group and the reported ownership is under the 5% threshold at 4.0%.

Who are the reporting persons named in the Schedule 13G/A for SCPH?

The reporting persons are Luther King Capital Management Corporation and J. Luther King, Jr. (the latter signing as President).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/08/2025 - 05:02 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 7)

scPharmaceuticals Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

810648105

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 810648105

1

Names of Reporting Persons

Luther King Capital Management Corporation

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,128,391.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,128,391.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,128,391.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.0 %

12

Type of Reporting Person (See Instructions)

IA, CO

SCHEDULE 13G

CUSIP No. 810648105

1

Names of Reporting Persons

J. Luther King, Jr.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,128,391.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,128,391.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,128,391.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.0 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: scPharmaceuticals Inc.
(b)	Address of issuer's principal executive offices: 25 Mall Road, Suite 203, Burlington, Massachusetts 01803
Item 2.
(a)	Name of person filing: Luther King Capital Management Corporation J. Luther King, Jr.
(b)	Address or principal business office or, if none, residence: 301 Commerce Street, Suite 1600, Fort Worth, Texas 76102
(c)	Citizenship: Luther King Capital Management Corporation - Delaware / J. Luther King, Jr. - USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 810648105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Luther King Capital Management Corporation - 2,128,391 J. Luther King, Jr. - 2,128,391
(b)	Percent of class: Luther King Capital Management Corporation - 4.0% J. Luther King, Jr. - 4.0%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Luther King Capital Management Corporation - 2,128,391 J. Luther King, Jr. - 2,128,391
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: Luther King Capital Management Corporation - 2,128,391 J. Luther King, Jr. - 2,128,391
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Luther King Capital Management Corporation

Signature:	/s/ J. Luther King, Jr.
Name/Title:	J. Luther King, Jr., President
Date:	10/08/2025

J. Luther King, Jr.

Signature:	/s/ J. Luther King, Jr.
Name/Title:	J. Luther King, Jr.
Date:	10/08/2025